nach oben

Annals of Nuclear Medicine

Erschienen in:

01.01.2010 | Case Report

Incidental finding of an ¹¹C-acetate PET-positive multiple myeloma

verfasst von: Sang Mi Lee, Tae Sung Kim, Jeong Won Lee, Hyun Woo Kwon, Yong Il Kim, Se Hun Kang, Seok Ki Kim

Erschienen in: Annals of Nuclear Medicine | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Multiple myeloma is a malignancy of plasma cells. The ¹⁸F-FDG PET findings of multiple myeloma have been reported previously. However, the ¹¹C-acetate PET findings have not been clarified. Here, we report a case of multiple myeloma detected with ¹¹C-acetate PET in a 51-year-old male patient with known hepatocellular carcinoma. The patient was admitted for management of a pathologic fracture of the right tibia. Imaging workup including X-ray, magnetic resonance image, bone scintigraphy; ¹⁸F-FDG led to a suspicion of metastatic bony lesions. Further, these lesions showed increased uptake on ¹¹C-acetate PET. Wide excision of the right tibia was performed, and histopathological examination of the lesion confirmed multiple myeloma. This case illustrates the characteristic ¹¹C-acetate PET findings of multiple myeloma.

Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002;31:690–4.CrossRefPubMed

El-Shirbiny AM, Yeung H, Imbriaco M, Michaeli J, Macapinlac H, Larson SM. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma. J Nucl Med. 1997;38:1208–10.PubMed

Tirovola EB, Biassoni L, Britton KE, Kaleva N, Kouykin V, Malpas JS. The use of 99mTc-MIBI scanning in multiple myeloma. Br J Cancer. 1996;74:1815–20.PubMed

Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol. 2005;184:1199–204.PubMed

Cholewinski W, Castellon I, Raphael B, Heiba SI. Value of precise localization of recurrent multiple myeloma with F-18 FDG PET/CT. Clin Nucl Med. 2009;34:1–3.CrossRefPubMed

Nanni C, Zamagni E, Cavo M, Rubello D, Tacchetti P, Pettinato C, et al. 11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. World J Surg Oncol. 2007;5:68.CrossRefPubMed

Dankerl A, Liebisch P, Glatting G, Friesen C, Blumstein NM, Kocot D, et al. Multiple myeloma: molecular imaging with 11C-methionine PET/CT—initial experience. Radiology. 2007;242:498–508.CrossRefPubMed

Roeda D, Dollé F, Crouzel C. An improvement of 11C acetate synthesis—non-radioactive contaminants by irradiation-induced species emanating from the 11C carbon dioxide production target. Appl Radiat Isot. 2002;57:857–60.CrossRefPubMed

Lecouvet FE, Malghem J, Michaux L, Maldague B, Ferrant A, Michaux JL, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey. Br J Haematol. 1999;106:35–9.CrossRefPubMed

10.

Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, et al. Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol. 1999;104:723–9.CrossRefPubMed

11.

Tertti R, Alanen A, Remes K. The value of magnetic resonance imaging in screening myeloma lesions of the lumbar spine. Br J Haematol. 1995;91:658–60.CrossRefPubMed

12.

Durie BG, Waxman AD, D’Agnolo A, Williams CM. Whole-body ¹⁸F-FDG PET identifies high-risk myeloma. J Nucl Med. 2002;43:1457–63.PubMed

13.

Mileshkin L, Blum R, Seymour JF, Patrikeos A, Hicks RJ, Prince HM. A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma. Eur J Haematol. 2004;72:32–7.CrossRefPubMed

14.

Vavere AL, Kridel SJ, Wheeler FB. Lewis JS.¹¹C-acetate as PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med. 2008;49(21):327–34.CrossRefPubMed

15.

Abiko T, Koizumi S, Takanami I. Dual primary subclavicular angiosarcoma and lung cancer imaging with C-11 acetate PET and FDG PET. Clin Nucl Med. 2009;34:302–4.CrossRefPubMed

16.

Nomori H, Shibata H, Uno K, Iyama K, Honda Y, Nakashima R, et al. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma. J Thorac Oncol. 2008;3:1427–32.PubMed

17.

Ho CL, Yu SC, Yeung DW. ¹¹C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213–21.PubMed

18.

Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol. 2001;28:117–22.CrossRefPubMed

19.

Stjernholm RL. Carbohydrate metabolism in leukocytes. VII. Metabolism of glucose, acetate, and propionate by human plasma cells. J Bacteriol. 1967;93:1657–61.PubMed

Titel: Incidental finding of an 11C-acetate PET-positive multiple myeloma
verfasst von: Sang Mi Lee
Tae Sung Kim
Jeong Won Lee
Hyun Woo Kwon
Yong Il Kim
Se Hun Kang
Seok Ki Kim
Publikationsdatum: 01.01.2010
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 1/2010
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-009-0325-6

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Correlation analysis of measurement result between accelerator mass spectrometry and gamma counter

Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma

Development of motion correction technique for cardiac 15O-water PET study using an optical motion tracking system

18F-FDG PET imaging of progressive massive fibrosis

Erratum to: Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction

Incidental detection of Sertoli–Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome